| Period Ending | 31-Mar-2012 | 31-Mar-2011 | 31-Mar-2010 |
|---|
|
Total Revenue
|
2,746,000
|
2,553,000
|
2,363,000
| | Cost of Revenue | 1,528,000 | 1,522,000 | 1,386,000 | | |
Gross Profit
|
1,218,000
|
1,031,000
|
976,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 847,000 | 725,000 | 698,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 360,000 | 313,000 | 313,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
11,000
|
(8,000)
|
(35,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 241,000 | 62,000 | 98,000 |
|
Earnings Before Interest And Taxes | 252,000 | 54,000 | 62,000 |
|
Interest Expense | 149,000 | 92,000 | 93,000 |
|
Income Before Tax | 103,000 | (38,000) | (31,000) |
|
Income Tax Expense | 103,000 | 17,000 | (17,000) |
|
Minority Interest | 83,000 |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 65,000 | (182,000) | (85,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
65,000
|
(182,000)
|
(85,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
65,000
|
(182,000)
|
(85,000)
|
|